Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Third Harmonic Bio (THRD) Competitors

Third Harmonic Bio logo

THRD vs. MDXG, PGEN, RAPP, TNGX, MNMD, BGM, EYPT, OCS, ANAB, and FTRE

Should you be buying Third Harmonic Bio stock or one of its competitors? The main competitors of Third Harmonic Bio include MiMedx Group (MDXG), Precigen (PGEN), Rapport Therapeutics (RAPP), Tango Therapeutics (TNGX), Mind Medicine (MindMed) (MNMD), BGM Group (BGM), Eyepoint Pharmaceuticals (EYPT), Oculis (OCS), AnaptysBio (ANAB), and Fortrea (FTRE). These companies are all part of the "med - biomed/gene" industry.

Third Harmonic Bio vs. Its Competitors

Third Harmonic Bio (NASDAQ:THRD) and MiMedx Group (NASDAQ:MDXG) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, institutional ownership, dividends, analyst recommendations, risk and earnings.

94.0% of Third Harmonic Bio shares are held by institutional investors. Comparatively, 79.2% of MiMedx Group shares are held by institutional investors. 7.8% of Third Harmonic Bio shares are held by insiders. Comparatively, 1.7% of MiMedx Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, MiMedx Group had 1 more articles in the media than Third Harmonic Bio. MarketBeat recorded 1 mentions for MiMedx Group and 0 mentions for Third Harmonic Bio. MiMedx Group's average media sentiment score of 0.83 beat Third Harmonic Bio's score of 0.00 indicating that MiMedx Group is being referred to more favorably in the news media.

Company Overall Sentiment
Third Harmonic Bio Neutral
MiMedx Group Positive

MiMedx Group has higher revenue and earnings than Third Harmonic Bio. Third Harmonic Bio is trading at a lower price-to-earnings ratio than MiMedx Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Third Harmonic BioN/AN/A-$45.47M-$0.62-8.68
MiMedx Group$348.88M2.87$42.42M$0.2132.25

Third Harmonic Bio presently has a consensus target price of $5.00, suggesting a potential downside of 7.06%. MiMedx Group has a consensus target price of $12.00, suggesting a potential upside of 77.17%. Given MiMedx Group's stronger consensus rating and higher possible upside, analysts plainly believe MiMedx Group is more favorable than Third Harmonic Bio.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Third Harmonic Bio
0 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
MiMedx Group
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

MiMedx Group has a net margin of 8.84% compared to Third Harmonic Bio's net margin of 0.00%. MiMedx Group's return on equity of 23.03% beat Third Harmonic Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
Third Harmonic BioN/A -19.27% -18.67%
MiMedx Group 8.84%23.03%17.09%

Third Harmonic Bio has a beta of 2.12, suggesting that its share price is 112% more volatile than the S&P 500. Comparatively, MiMedx Group has a beta of 1.73, suggesting that its share price is 73% more volatile than the S&P 500.

Summary

MiMedx Group beats Third Harmonic Bio on 12 of the 15 factors compared between the two stocks.

Get Third Harmonic Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for THRD and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding THRD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

THRD vs. The Competition

MetricThird Harmonic BioMED IndustryMedical SectorNASDAQ Exchange
Market Cap$242.80M$3.42B$6.15B$10.77B
Dividend YieldN/A2.26%5.71%4.83%
P/E Ratio-4.3723.3129.7228.55
Price / SalesN/A271.94499.21189.70
Price / CashN/A45.1236.6160.67
Price / Book0.8510.4012.016.61
Net Income-$45.47M-$52.62M$3.32B$276.82M

Third Harmonic Bio Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
THRD
Third Harmonic Bio
N/A$5.38
flat
$5.00
-7.1%
N/A$242.80MN/A-4.37N/A
MDXG
MiMedx Group
3.1866 of 5 stars
$6.58
+1.1%
$12.00
+82.4%
+18.1%$963.22M$348.88M31.33870Upcoming Earnings
PGEN
Precigen
4.3477 of 5 stars
$3.20
-0.3%
$8.25
+157.8%
+352.1%$956.49M$4.34M-7.62190
RAPP
Rapport Therapeutics
3.2471 of 5 stars
$24.88
-5.0%
$35.33
+42.0%
+1.3%$955.88MN/A-9.95N/APositive News
Gap Up
TNGX
Tango Therapeutics
2.0955 of 5 stars
$8.70
+2.7%
$10.50
+20.7%
+20.1%$942.37M$24.30M-6.5490Trending News
Analyst Forecast
Gap Up
MNMD
Mind Medicine (MindMed)
3.3071 of 5 stars
$12.62
+3.0%
$27.83
+120.5%
+100.5%$932.08MN/A-8.2540Gap Up
BGM
BGM Group
0.8429 of 5 stars
$9.60
+1.2%
N/A+23.6%$922.64M$25.10M0.00298News Coverage
Analyst Forecast
Short Interest ↑
Gap Up
EYPT
Eyepoint Pharmaceuticals
2.2662 of 5 stars
$13.16
-1.3%
$26.86
+104.1%
+15.5%$919.49M$51.90M-4.91120
OCS
Oculis
2.7931 of 5 stars
$21.54
+2.6%
$41.00
+90.3%
+31.3%$916.90MN/A-8.072Short Interest ↑
ANAB
AnaptysBio
2.8588 of 5 stars
$31.85
-1.9%
$52.00
+63.3%
-2.2%$908.78M$91.28M-7.11100Analyst Forecast
FTRE
Fortrea
3.2504 of 5 stars
$9.55
-2.7%
$12.17
+27.4%
-41.7%$891.66M$2.70B-0.8415,500

Related Companies and Tools


This page (NASDAQ:THRD) was last updated on 10/24/2025 by MarketBeat.com Staff
From Our Partners